Science Corporation's brain tech is worth $3.5 billion after new funding
The new investment brings the brain technology company to a valuation of $3.5 billion. The organization plans to use the proceeds to expand its anti-blindness operations.
Key Takeaways
- Science Corporation secured $400 million in Series D funding, as reported on November 17, 2026.
Following this financial backing, the brain technology developer reached a valuation of $3.5 billion.
- This capital infusion highlights growing commercial investment in neurotechnology solutions targeted at medical applications.
Science Corporation secured a $400 million Series D funding round reported on November 17, 2026.
- Science Corp intends to use the capital to scale up its anti-blindness business.
- The brain technology developer reached a total valuation of $3.5 billion following the round.
Stats & Key Facts
- #Science Corporation secured $400 million in a Series D funding round announced on November 17, 2026.
- #The new investment brings the brain technology company to a valuation of $3.5 billion.
- #Science Corporation secured $400 million in Series D funding, as reported on November 17, 2026.
- #Following this financial backing, the brain technology developer reached a valuation of $3.5 billion.
This capital infusion highlights growing commercial investment in neurotechnology solutions targeted at medical applications. Science Corporation secured a $400 million Series D funding round reported on November 17, 2026. The brain technology developer reached a total valuation of $3.5 billion following the round.
For more details please read the original article at TechCrunch AI.
Continue Learning
Comments
Comments appear only after moderation. Your email identifies your submission to the moderator and is never displayed here.
No approved comments yet.